Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERK-mediated monocyte activation. [PDF]
Bohlen J+63 more
europepmc +1 more source
Case Report: A Novel Pathomechanism in PEComa by the Loss of Heterozygosity of TP53. [PDF]
Butz H+5 more
europepmc +1 more source
F. Goudie+5 more
semanticscholar +1 more source
Exosome as bioactive nanovesicle for diagnostic and therapeutic applications in periodontitis
This review introduces the mechanism that exosomes participate in the pathogenesis of periodontitis and their potential as biomarkers for early diagnosis and summarizes the application of cell‐ or plant‐derived exosomes or engineered exosomes in periodontitis or periodontal regeneration while proposing the perspective of translational application of ...
Yu Wang+6 more
wiley +1 more source
KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition. [PDF]
Fey SK+16 more
europepmc +1 more source
Genome-scale patterns in the loss of heterozygosity incidence in Saccharomyces cerevisiae. [PDF]
Tutaj H, Pirog A, Tomala K, Korona R.
europepmc +1 more source
Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas
Seung‐Hoon Lee+6 more
openalex +1 more source
Genetic Instability and Aberrant DNA Methylation in Chronic Hepatitis and Cirrhosis—A Comprehensive Study of Loss of Heterozygosity and Microsatellite Instability at 39 Loci and DNA Hypermethylation on 8 CpG Islands in Microdissected Specimens From Patients With Hepatocellular Carcinoma [PDF]
Yutaka Kondo+5 more
openalex +1 more source
Exome sequencing-based copy-number variation and loss of heterozygosity detection: ExomeCNV
J. Sathirapongsasuti+7 more
semanticscholar +1 more source
Mechanism and role of regulated cell death in tumor immunity and immunotherapy
Abstract Cancer immune checkpoint inhibitors (ICIs) have brought breakthroughs, but only about one‐third of cancer patients benefit from ICIs. In recent years, targeting non‐apoptotic regulated cell death (RCD) subtypes, such as ferroptosis, necroptosis, autophagy, cuproptosis, and pyroptosis, has emerged as a novel strategy in cancer therapy due to ...
Jingwen Hu+4 more
wiley +1 more source